PURLs

Deliver or Wait with Late Preterm Membrane Rupture?

Author and Disclosure Information

 

References

WHAT’S NEW?

Largest study to show no increased sepsis with expectant management

Two prior RCTs (involving 736 women) evaluated expectant management versus induction in the late preterm stage of pregnancy. No increased risk for neonatal sepsis with expectant management was found in either study.8,9

However, those studies did not have sufficient power to show a statistically significant change in any of the outcomes. The PPROMT study is the largest to indicate that immediate birth increases infant risk for respiratory distress and duration of NICU/special care stay and increases the mother’s risk for cesarean section. It also showed that risk for neonatal sepsis was not higher in the expectant management group.

CAVEATS

Singleton pregnancies only

Delivery of the infants in the expectant management group was not by specified protocol; each birth was managed according to the policies of the local center and clinician judgment. This created variation in fetal and maternal monitoring. The majority of women in both groups (92% to 93%) received intrapartum antibiotics. Expectant management should include careful monitoring for infection and hemorrhage. If one of these occurs, immediate delivery may be necessary.

The study participants all had singleton pregnancies; this recommendation cannot be extended to non-singleton pregnancies. However, a prior cesarean section was not an exclusion criterion for the study, and these recommendations would be valid for that group of women, as well.

CHALLENGES TO IMPLEMENTATION

Going against the tide of ACOG

The most recent ACOG guidelines (updated October 2016) recommend induction of labor for women with ruptured membranes in the late preterm stages.5 This may present a challenge to widespread acceptance of expectant management for PPROM.

ACKNOWLEDGEMENT

The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.

Copyright © 2016. The Family Physicians Inquiries Network. All rights reserved.

Reprinted with permission from the Family Physicians Inquiries Network and The Journal of Family Practice. 2016;65(11):820-822.

Pages

Recommended Reading

Women and Heart Disease
Clinician Reviews
CDC: Improvement in breast cancer mortality slower among black women
Clinician Reviews
When is it time to stop hormone therapy?
Clinician Reviews
Early menopause a risk factor for type 2 diabetes
Clinician Reviews
Injectable male contraceptive on par with other reversible options
Clinician Reviews
Chagas Disease: Creeping into Family Practice in the United States
Clinician Reviews
It’s not easy to identify clinical depression in menopause
Clinician Reviews
Examining the safety of lipid-lowering drugs in pregnancy
Clinician Reviews
Make HIV testing of adolescents routine
Clinician Reviews
Low-dose cyclophosphamide unlikely to impair fertility in lupus patients
Clinician Reviews

Related Articles